Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Long-Term Investments (2016 - 2025)

Tandem Diabetes Care's Long-Term Investments history spans 5 years, with the latest figure at $60.4 million for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 18.98% year-over-year to $60.4 million; the TTM value through Dec 2025 reached $60.4 million, down 18.98%, while the annual FY2025 figure was $60.4 million, 18.98% down from the prior year.
  • Long-Term Investments reached $60.4 million in Q4 2025 per TNDM's latest filing, down from $64.9 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $74.5 million in Q4 2024 to a low of $60.4 million in Q4 2025.